Related Experiment Videos
The long-term outcome of nonsuppurative otitis media with effusion
Insights
This study on nonsuppurative otitis media with effusion (OME) found no significant difference in resolution rates between pseudoephedrine, chlorpheniramine, and placebo treatments. Older children with unilateral OME showed the best resolution likelihood.
Area of Science:
- Pediatrics
- Otolaryngology
- Infectious Diseases
Background:
- Nonsuppurative otitis media with effusion (OME) is a common pediatric condition.
- Understanding OME's natural course and treatment efficacy is crucial for effective management.
- Previous studies have explored various interventions, but definitive outcomes require further investigation.
Purpose of the Study:
- To evaluate the 12-week outcome of nonsuppurative otitis media with effusion (OME) in children.
- To compare the efficacy of pseudoephedrine, chlorpheniramine, and placebo in managing OME.
- To identify factors influencing OME resolution or progression.
Main Methods:
- A double-blind, placebo-controlled study enrolled 74 children with OME.
- Participants were randomized into three groups: pseudoephedrine, chlorpheniramine, or placebo.
- Children were monitored over 12 weeks with follow-up examinations at 2, 4, 8, and 12 weeks.
Main Results:
- Of 66 children completing the study, 44% experienced OME resolution within 12 weeks.
- 38% developed acute suppurative otitis media, and 14% had unresolved OME.
- No significant differences in effusion resolution were observed between the treatment groups.
- The highest incidence of both suppurative otitis media and OME resolution occurred by week 2.
Conclusions:
- Pseudoephedrine and chlorpheniramine did not demonstrate a significant advantage over placebo for OME resolution.
- Early resolution or development of acute suppurative otitis media was most common within the first two weeks.
- Children aged 18 months or older with unilateral effusion had a higher likelihood of OME resolution.
Abstract:
Seventy-four children were enrolled in a double-blind placebo-controlled study to define the outcome of nonsuppurative otitis media with effusion (OME) over a 12-week period. Participants were randomly assigned to one of three treatment groups: pseudoephedrine (4 mg/kg/day), chlorpheniramine (0.35 mg/kg/day), or placebo. The children were reexamined at 2, 4, 8, and 12 weeks after enrollment unless earlier dismissed from the study because OME resolved or acute suppurative otitis media developed. Of the 66 children completing the study protocol, 44 percent had resolved OME, 38 percent developed acute suppurative otitis media, 14 percent had unresolved OME, and 4 percent developed severe hearing loss or medication side effects by the end of 12 weeks. The greatest incidence of both suppurative otitis media and resolution of OME occurred by 2 weeks of follow-up. There was no significant difference in resolution of effusion between treatment groups. Children who were 18 months of age or older with unilateral effusion had the best likelihood of resolution.